JN-International Medical Corporation is a U.S.-based biopharmaceutical corporation which since 1998 has been focused on developing vaccines and diagnostics for infectious disease for developing countries. JNIMC has overseas business offices and clinical trial centers located in Abidjan, Ivory Coast…
JN-International Medical Corporation is a U.S.-based biopharmaceutical corporation which since 1998 has been focused on developing vaccines and diagnostics for infectious disease for developing countries. JNIMC has overseas business offices and clinical trial centers located in Abidjan, Ivory Coast in Africa with vaccine cold chain facilities in Burkina Faso. JNIMC partners with Global Health Organizations such as the Clinton Global Initiative, the Global Business Coalition, New York President's Malaria Initiative and PEPFAR. JNI also partners with several other non-profit global health organizations, NGOs, local governments and communities in developing countries to address the health issues related to HIV-AIDS, Malaria, Tuberculosis and Bacterial Meningitis that scourges the underserved communities in West Africa, South East Asia and Latin America.
Team (1)
Sectors JN-international Medical Corporation serves:
Life Sciences
Join Axial's Private M&A Platform
JN-international Medical Corporation connects with qualified M&A advisors through the Axial Platform.
Looking for Buyers?
Reach this investor and hundreds more on Axial. No cost to advisors.
